How Much Does Descovy Cost?
Descovy (Emtricitabine/TAF) costs an average of $2,418 per Medicare Part D claim, with total Medicare spending of $1567.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $2,418 |
| Total Medicare Spending | $1567.0M |
| Total Claims | 648,000 |
| Beneficiaries | 86,000 |
| Generic Available | Yes |
| Year-Over-Year Change | +12.4% |
Descovy (Emtricitabine/TAF) costs an average of $2,418 per Medicare Part D claim, with total Medicare spending of $1567.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.